Mark Pobanz
Dow AgroSciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark Pobanz.
Bioorganic & Medicinal Chemistry | 2009
Timothy C. Johnson; Timothy Martin; Richard K. Mann; Mark Pobanz
The discovery of the sulfonamide herbicides, which inhibit the enzyme acetolactate synthase (ALS), has resulted in many investigations to exploit their herbicidal activity. One area which proved particularly productive was the N-aryltriazolo[1,5-c]pyrimidine sulfonamides, providing three commercial herbicides, cloransulam-methyl, diclosulam and florasulam. Additional structure-activity investigations by reversing the sulfonamide linkage resulted in the discovery of triazolopyrimidine sulfonamides with cereal crop selectivity and high levels of grass and broadleaf weed control. Research efforts to exploit these high levels of weed activity ultimately led to the discovery of penoxsulam, a new herbicide developed for grass, sedge and broadleaf weed control in rice. Synthetic efforts and structure-activity relationships leading to the discovery of penoxsulam will be discussed.
Pest Management Science | 2017
William H. Dent; Mark Pobanz; Chaoxian Geng; Thomas C. Sparks; Gerald B. Watson; Theodore J. Letherer; Kenneth W. Beavers; Cathy D. Young; Yelena Adelfinskaya; Ronald Ross; Greg Whiteker; James M. Renga
BACKGROUND γ-Amino butyric acid (GABA) antagonists are proven targets for control of lepidopteran and other pests. New heterocyclic compounds with high insecticidal activity were discovered using a competitive-intelligence-inspired scaffold-hopping approach to generate analogs of fipronil, a known GABA antagonist. These novel aryl heterocyclic amines (AHAs) displayed broad-spectrum activity on a number of chewing insect pests. RESULTS Through >370 modifications of the core AHA structure, a 7-pyrazolopyridine lead molecule was found to exhibit much improved activity on a number of insect pests. In field trial studies, its performance was 2-4 times lower than commercial standards and also appeared to be species dependent, with good activity seen for larvae of Spodoptera exigua, but inactivity on larvae of Trichoplusia ni. CONCLUSION An extensive investigational biology effort demonstrated that these AHA analogs appear to have multiple modes of action, including GABA receptor antagonism and mitopotential or uncoupler activity. The limited capability in larvae of T. ni to convert the lead molecule to its associated open form correlates with the low toxicity of the lead molecule in this species. This work has provided information that could aid investigations of novel GABA antagonists.
Archive | 2009
Timothy Boebel; Kristy Bryan; Carla Jean Rasmussen Klittich; Beth Lorsbach; Timothy Martin; W. John Owen; Mark Pobanz; Michael Sullenberger; Jeffery Webster; Chenglin Yao
Archive | 1997
Timothy C. Johnson; Robert J. Ehr; Richard D Johnston; William A. Kleschick; Timothy Martin; Mark Pobanz; John C. Van Heertum; Richard K. Mann
Archive | 2001
Timothy C. Johnson; John Cord Vanheertum; David G. Ouse; Mark Pobanz; Kim E. Arndt; David Keith Walker
Archive | 2010
Timothy Boebel; Kristy Bryan; Beth Lorsbach; Timothy Martin; W. John Owen; Mark Pobanz; Scott Thornburgh; Jeffery Webster; Chenglin Yao
Archive | 2010
Timothy Boebel; Kristy Bryan; Beth Lorsbach; Timothy Martin; W. John Owen; Mark Pobanz; Scott Thornburgh; Jeffery Webster; Chenglin Yao
Archive | 2010
Timothy Boebel; Kristy Bryan; Beth Lorsbach; Timothy Martin; W. John Owen; Mark Pobanz; Scott Thornburgh; Jeffery Webster; Chenglin Yao
Archive | 2010
Timothy Boebel; Kristy Bryan; Beth Lorsbach; Timothy Martin; W. John Owen; Mark Pobanz; Scott Thornburgh; Jeffery Webster; Chenglin Yao
Archive | 2001
Michael Glenn Smith; Mark Pobanz; Gary A. Roth; Michael Allen Gonzalez